591741-72-9

Basic information

• Product Name: 1H-Imidazole-4-carboxylic acid, 5-methyl-1,2-diphenyl-, methyl ester
• CAS NO: 591741-72-9
• Molecular Formula: C18H16N2O2
• Molecular Weight: 292.337
• Mol File: 591741-72-9.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 1H-Imidazole-4-carboxylic acid, 5-methyl-1,2-diphenyl-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Imidazole-4-carboxylic acid, 5-methyl-1,2-diphenyl-, methyl ester(591741-72-9)
• EPA Substance Registry System: 1H-Imidazole-4-carboxylic acid, 5-methyl-1,2-diphenyl-, methyl ester(591741-72-9)

Safety Data

• Hazardous Substances Data: 591741-72-9(Hazardous Substances Data)

Upstream product

• 100-46-9 benzylamine 
• 4916-22-7 methyl (2Z)-3-(phenylamino)but-2-enoate 
• 4916-22-7 methyl 3-phenylaminobut-2-enoate 
• 62-53-3 aniline 
• 77320-41-3 2-benzoylamino-3-oxo-butyric acid methyl ester 

Downstream Products

• 787563-24-0 5-methyl-1,2-diphenyl-1H-imidazole-4-carboxylic acid 

Relevant articles and documents

Electrochemical synthesis of 1,2,4,5-tetrasubstituted imidazoles from enamines and benzylamines

An electrochemical method for synthesizing 1,2,4,5-tetrasubstituted imidazoles was developed under undivided electrolytic conditions. This synthesis was specifically realized based on electrochemical C(sp3)-H aminationviaenamines and amines. Readily available starting materials were used, avoiding the use of both transition metals and oxidants. The practicability of the method lies in its broad substrate adaptability and in its ability to provide a simple green pathway for synthesizing GABAAreceptor analogs.

FIVE-MEMBERED HETEROCYCLIC DERIVATIVE

The present invention relates to a compound represented by formula (I): a salt of the compound, or a solvate of the compound or the salt; a drug containing any of the compounds, the salts, and the solvates; a preventive and/or therapeutic agent for an ischemic disease containing any of the compounds, the salts, and the solvates; and a platelet coagulation inhibitor containing any of the compounds, the salts, and the solvates. The compound of the present invention is useful as a strong platelet coagulation inhibitor without inhibiting COX-1 or COX-2.